<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885376</url>
  </required_header>
  <id_info>
    <org_study_id>ING-001</org_study_id>
    <nct_id>NCT02885376</nct_id>
  </id_info>
  <brief_title>Study of Dentoxol® Mouthrinse for Oral Mucositis</brief_title>
  <official_title>Phase II Study of Dentoxol® Mouthrinse for Oral Mucositis Secondary to Radiation Therapy for Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ingalfarma SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ingalfarma SpA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the efficacy of Dentoxol® mouthrinse in
      reducing the severity of oral mucositis secondary to radiation therapy for head and neck
      cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of severe oral mucositis, defined as grade 3 or 4 on the World Health Organization (WHO) scale</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of and time to onset of severe oral mucositis, defined as grade 3 or 4 on the World Health Organization (WHO) scale.</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mouth pain scores, as measured in the Oral Mucositis Daily Questionnaire (OMDQ).</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to eat, drink, and swallow, as measured in the Oral Mucositis Daily Questionnaire (OMDQ).</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight loss, as measured by the difference between weight on first and last day of radiation therapy.</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of opioid analgesics for oral mucositis pain, as expressed in morphine equivalents.</measure>
    <time_frame>First day of radiation therapy through last day of radiation therapy (5-8 weeks)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Oral Mucositis</condition>
  <arm_group>
    <arm_group_label>Dentoxol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dentoxol® is a proprietary mouthrinse that has anti-inflammatory, antimicrobial and analgesic effects. Subjects will use Dentoxol® mouthrinse 5 times each day, starting on the first day of radiation therapy and ending on the last day of radiation therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo rinse will be identical in color, taste and consistency as the Dentoxol rinse and will be packaged in identical bottles with the same labels. Subjects will use placebo mouthrinse 5 times each day, starting on the first day of radiation therapy and ending on the last day of radiation therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dentoxol</intervention_name>
    <description>Mouthrinse</description>
    <arm_group_label>Dentoxol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mouthrinse</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned to receive radiation therapy for cancer of the oral cavity, oropharynx,
             nasopharynx, hypopharynx or larynx, with or without concomitant chemotherapy.

          -  Planned to receive at least 5000cGy radiation therapy to at least 2 of 12
             pre-specified areas in the oral cavity

        Exclusion Criteria:

          -  Unable to give written informed consent

          -  Known allergy/intolerance to any component of the study rinse or placebo

          -  Planning to use any contraindicated medications during the study period (pain
             medications are allowed)

          -  Age below 18 years

          -  Pregnant or nursing (If the patient is a woman of childbearing potential, a pregnancy
             test must be performed within fourteen days before enrollment in the study)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastián Sole</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica IRAM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastián Sole</last_name>
    <phone>+56 2 2754 1711</phone>
    <email>ssole@iram.cl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinica IRAM</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fundación Arturo López Pérez</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional del Cáncer</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mucositis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

